2016.5.19
Novo Nordisk A/S (NYSE:NVO) is expected to announce second quarter financial results before market open (confirmed) on August 05, 2016. The company lost about -2.1 percent in value since last earnings when it was at $56.04. Based on the most relevant historical data, there is a 66.67 percent probability for share price to go down following the next earnings report. Looking further into earnings reaction history, the stock had moved down 4 times out of last 6 quarters. It has topped earnings-per-share estimates 33% of the time in its last 12 earnings reports. It missed earnings on 1 occasions, and it has met expectations 0 time.
So how did NVO’s earnings announcements affect its stock price in the past few quarters?
Novo Nordisk A/S (NVO) Earnings Reaction History
Overall, the average earnings surprise was 2.18 percent over the past four quarters. Back on April 29, 2016, it posted earnings per share at $0.55 which met the consensus $0.55 projection (no surprise). Revenue came in at 4.03B versus consensus estimate of 4.14B. The stock dropped -0.45 percent the day following the earnings was released, and on 7th day price change was -4.46 percent.
On February 3, 2016, it posted earnings per share at $0.48 versus the consensus estimate of $0.47 (positive surprise of 2.1%). Revenue of 4.24B was above the $4.22B analysts had expected. The stock dropped -6.1% the day following the earnings was released, and on 7th day price change was -15.4%.
On October 29, 2015, it posted earnings per share at $0.49, topping the consensus estimate of $0.47 (positive surprise of 4.3%). Revenue for the quarter was $3.99B while analysts had expected revenues to come in at $4.06B. The stock dropped -6.7% the day following the earnings was released, and on 7th day price change was -5.77%.
On August 6, 2015, it posted earnings per share at $0.45 compared with the consensus estimate of $0.44 (positive surprise of 2.3%). That came on revenues of $3.96B for the quarter. Analysts had expected $4.03B in revenue.
Novo Nordisk A/S Earnings Expectations
In front of Q2 earnings release, Wall Street is expecting earnings per share of $0.58. The analysts’ current consensus range is $0.58-$0.58 for EPS. The market consensus range for revenue is $4.3B-$4.3B, with an average of $4.3B.
Novo Nordisk A/S (NYSE:NVO) last closed at $54.25, sending the company’s market cap around $138.03B. The consensus 12-month price target from brokerage firms covering the stock is $60.1. The share price has declined -8.5% from its best level in 52 weeks and advanced -4.94% this year. It recently traded in a range of $54.14-$54.76 at a volume of 1574000 shares. The stock ended last trading session with the price nearly -1.27 lower for the last 5 trading days, rebounding 19.58% from its 52-week low.
설명웹사이트 방문